Phase 3 trials showed Vanrafia slowed the decline in kidney function for adults with the progressive autoimmune kidney ...

A total of 340 biopsy-confirmed IgAN patients were randomised to daily oral Vanrafia or a placebo for approximately 132 weeks.

Atrasentan shows clinically meaningful effects on kidney function in IgA nephropathy patients, including those receiving SGLT2 inhibitors.

In an interview, Jackson Peter Kim, MD, clinical assistant professor in the Division of Nephrology at Stanford Health Care, ...

It’s déjà vu all over again. Just as the kidney disease space becomes increasingly competitive, Novartis has found itself intending to turn a statistical miss into a regulatory win. | It’s déjà vu all ...

Kidney disease often creeps in silently, and many patients aren’t diagnosed until major damage is already done. New research ...

Originally developed as a more-potent follow-up to Roche's long-established CD20-directed antibody Rituxan (rituximab) for ...

Older adults living with heart failure with preserved ejection fraction (HFpEF) are frequently labeled as having chronic ...

Aims Heart failure (HF) often coexists with chronic kidney disease (CKD), impacting prognosis. This study aims to evaluate ...

What if a simple urine test could warn you about hidden kidney damage before symptoms even appear? It can-and that's exactly why Oscar-winning actress Octavia Spencer, 55, and Modern Family star Sofia ...